Canada Calls For Drug Ad Moratorium

4 March 1996

The federal Drugs Directorate of Health Canada's Health Protection Branch has asked pharmaceutical manufacturers for a voluntary eight-month moratorium on consumer advertising of pharmaceuticals.

The agency is also proposing to hold a conference in the late spring to discuss whether the current Food and Drug Act regulations covering such advertising need to be changed.

While the Act currently prohibits any direct-to-consumer advertising of drugs other than with respect to "the brand name, proper name, common name, price and quantity of the drug," the Directorate has noted its concern at the growing amount of advertisements in consumer journals which gets around these prohibitions by providing every detail of the product except its name.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight